Science 1 March 2013:
Vol. 339 no. 6123 p. 1024
DOI: 10.1126/science.339.6123.1024
- NEWS & ANALYSIS
CLINICAL TRIALS
European countries are embroiled in a debate over how to redo rules for clinical trials, an effort to replace a controversial 12-year-old directive that critics say bound human research studies in red tape. But preserving stringent patient protections without tipping into excessive bureaucracy—and getting 27 countries to agree—is no easy task.